FDA Approves 10 New Precision Cancer Treatments in 12 Months

The FDA approved 10 new molecularly targeted cancer therapies in just one year, offering hope to patients with breast, lung, ovarian, prostate, brain, and blood cancers.

These precision treatments attack cancer cells while sparing healthy tissue, marking a significant shift in how doctors fight the disease.